Robinhood Markets

Mcdonald's

Cisco Systems

CVS Health

DuPont de Nemours

Market to Watch: Jobs Report, Earnings from Robinhood, McDonald's, and Cisco Systems

西维斯

CVS Health's 15min chart sees MACD Death Cross, Bollinger Bands Narrowing.

CVS Health's 15min Chart Triggers Bollinger Bands Narrowing, KDJ Death Cross Alert.

CVS Health to offer lower-cost biosimilar medications starting April 1.

CVS Health Corp Sees Increased Stake from Zurcher Kantonalbank, Reports Q4 Earnings

Catalyst<ul> <li>Most analysts rate CVS Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Fund flow analysis indicates negative net inflow trends across all order size buckets.</li></ul>

Key Factors

CVS Health announced it will replace branded osteoporosis drugs Prolia and Forteo with biosimilars and generic alternatives starting April 1 on major formularies. CVS Health raised its full-year 2025 earnings per share guidance to $6.60 to $6.70 and provided 2026 EPS guidance of $7.00 to $7.20. CVS Health announced a partnership with NovoCare, contributing to a 2.65% stock increase amid strategic expansion initiatives. CVS Health announced a pharmacist-led fertility care expansion and 300+ layoffs in Q1, contributing to a 3% stock surge. Zurcher Kantonalbank increased its stake in CVS Health by 8.05%, owning 1,585,235 shares valued at $125.8 million.

Recent Updates

CVS News